5 Ways Project 2025 Puts Profits Over Patients ArticleSeptember 4, 2024 5 Ways Project 2025 Puts Profits Over Patients Project 2025’s agenda to put profits ahead of patients would hurt American consumers for decades to come. Sep 4, 2024 Nicole Rapfogel, Jill Rosenthal, Marquisha Johns, 2 More Brian Keyser, Andrea Ducas
Project 2025’s Medicare Changes Would Restrict Older Americans’ Access to Care and Imperil the Program’s Financial Health ArticleAugust 15, 2024 Project 2025’s Medicare Changes Would Restrict Older Americans’ Access to Care and Imperil the Program’s Financial Health By making Medicare Advantage—privatized Medicare—the default option for all Medicare enrollees, Project 2025’s plan would lead to a multibillion-dollar giveaway to corporations that would limit older Americans’ health care choices while putting Medicare’s future at risk. Aug 15, 2024 Brian Keyser, Andrea Ducas
6 Medicare Advantage Data Gaps That the Centers for Medicare and Medicaid Services Must Fill ArticleJuly 29, 2024 6 Medicare Advantage Data Gaps That the Centers for Medicare and Medicaid Services Must Fill The Centers for Medicare and Medicaid Services must address gaps in Medicare Advantage broker compensation, network adequacy, prior authorization, supplemental benefits use, disenrollment, and enrollee out-of-pocket cost expenditure data. Jul 29, 2024 Brian Keyser, Andrea Ducas
CAP Responds to Request for Information on Consolidation in Health Care Markets ArticleJune 24, 2024 CAP Responds to Request for Information on Consolidation in Health Care Markets The Center for American Progress submitted a response to the U.S. Department of Justice, Federal Trade Commission, and U.S. Department of Health and Human Services’ request for information on consolidation in health care markets. Jun 24, 2024 Natasha Murphy, Nicole Rapfogel, Alexandra Thornton, 3 More Marc Jarsulic, Andrea Ducas, Brian Keyser
Film Screening: ‘The Bitter Pill’ Past EventMay 30, 2024 Film Screening: ‘The Bitter Pill’ A documentary about the biggest civil litigation in U.S. history that took on pharmaceutical companies and their role in the opioid epidemic. The film will be followed by a discussion with the filmmakers. May 30, 2024
Lowering Prescription Drug Costs To Advance Health Equity: A Conversation With HHS Secretary Xavier Becerra Past EventMarch 29, 2024 Lowering Prescription Drug Costs To Advance Health Equity: A Conversation With HHS Secretary Xavier Becerra Join CAP for a conversation highlighting how the Inflation Reduction Act’s Medicare prescription drug reforms will reduce health disparities. Mar 29, 2024
Medicare 2.0: Comprehensive Reform To Strengthen America’s Health Insurance Program for Older Adults ReportMarch 19, 2024 Medicare 2.0: Comprehensive Reform To Strengthen America’s Health Insurance Program for Older Adults This report details five key Medicare reform principles for traditional Medicare and Medicare Advantage. Mar 19, 2024 Micah Johnson, Donald Berwick, Richard J. Gilfillan, 1 More Andrea Ducas
Ending Overpayment in Medicare Advantage ReportMarch 19, 2024 Ending Overpayment in Medicare Advantage A new Center for American Progress analysis finds that Medicare Advantage (MA) plans are overpaid by 22 to 39 percent; savings from curbing MA overpayments should be used to improve the Medicare program for all beneficiaries. Mar 19, 2024 Micah Johnson, Donald Berwick, Richard J. Gilfillan, 1 More Andrea Ducas
14 Years After the ACA’s Passage, Policymakers Should Build on Its Pillars of Affordable and Accessible Care ArticleMarch 18, 2024 14 Years After the ACA’s Passage, Policymakers Should Build on Its Pillars of Affordable and Accessible Care The Affordable Care Act was a landmark achievement, and policymakers should build on its successes to help ensure affordable, comprehensive health coverage for all Americans. Mar 18, 2024 Natasha Murphy, Andrea Ducas
CAP Files Amicus Curiae Briefs Highlighting Importance of the Inflation Reduction Act in Lowering Drug Prices ArticleJanuary 23, 2024 CAP Files Amicus Curiae Briefs Highlighting Importance of the Inflation Reduction Act in Lowering Drug Prices These briefs emphasize the benefits of the Inflation Reduction Act’s Medicare prescription drug price negotiation program for affordability and health equity. Jan 23, 2024 Sophia Weaver, Marquisha Johns, Andrea Ducas, 3 More Jamie Crooks, Devon Ombres, Ben Olinsky
Testimony Before the House Education and the Workforce Subcommittee on Health, Employment, Labor and Pensions In the NewsJanuary 11, 2024 Testimony Before the House Education and the Workforce Subcommittee on Health, Employment, Labor and Pensions Andrea Ducas testified before the House Education and the Workforce Health, Employment, Labor and Pensions Subcommittee about reducing health care costs. Jan 11, 2024 House Education and the Workforce Committee Andrea Ducas
CAP Files Amicus Curiae Brief Highlighting Importance of the Inflation Reduction Act in Lowering Drug Prices ArticleDecember 22, 2023 CAP Files Amicus Curiae Brief Highlighting Importance of the Inflation Reduction Act in Lowering Drug Prices This brief, filed by the Center for American Progress and the NAACP in response to Boehringer Ingelheim Pharmaceuticals Inc. v. U.S. Department of Health and Human Services et al., emphasizes the benefits of the Inflation Reduction Act’s Medicare prescription drug price negotiation program for affordability and health equity. Dec 22, 2023 Sophia Weaver, Marquisha Johns, Andrea Ducas